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Abstract 
Background: Adherence to the Mediterranean diet reduces the risk of all-cause and cardiovascular (CV) mortality 
and the incidence of CV events. However, most previous studies were performed in high-risk individuals. Our objec-
tive was to assess whether the adherence to the Mediterranean diet, evaluated by the MED score, was associated with 
all-cause and CV mortality and incidence of CV events in individuals at low CV risk from a population-based cohort, 
after a 12-year mean follow-up.
Methods: A cohort of 1658 individuals completed a validated food-frequency questionnaire in 2001–2003. The MED 
score was calculated by a 0–9 scale. Anthropometric, laboratory measurements, and the vital status were collected at 
baseline and during 2014. The baseline CV risk was estimated by the Framingham risk score. Participants were divided 
into two groups: individuals at low risk (CV < 10) and individuals with CV risk ≥10.
Results: During a 12-year mean follow-up, 220 deaths, 84 due to CV diseases, and 125 incident CV events occurred. 
The adherence to the Mediterranean diet was low in 768 (score 0–2), medium in 685 (score 4–5) and high in 205 
(score >6) individuals. Values of BMI, waist circumference, fasting glucose and insulin significantly decreased from low 
to high diet adherence only in participants with CV risk ≥10. In a Cox-regression model, the hazard ratios (HRs) in low-
risk individuals per unit of MED score were: HR = 0.83 (95 % CI 0.72–0.96) for all-cause mortality, HR = 0.75 (95 % CI 
0.58–0.96) for CV mortality, and HR = 0.79 (95 % CI 0.65–0.97) for CV events, after multiple adjustments. In individuals 
with CV risk ≥10, the MED score predicted incident CV events (HR = 0.85; 95 % CI 0.72–0.99), while the associations 
with all-cause (HR = 1.02; 95 % CI 0.90–1.15) and CV mortality (0.94; 95 % CI 0.76–1.15) were not significant.
Conclusions: Greater adherence to the Mediterranean diet was associated with reduced fatal and non fatal CV 
events, especially in individuals at low CV risk, thus suggesting the usefulness of promoting this nutritional pattern in 
particular in healthier individuals.
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Background
Findings from cohort studies have suggested that a 
high degree of adherence to the Mediterranean diet is 
associated with a reduction in all-cause and cardiovascu-
lar (CV) mortality and CV events [1–33].
The components of the Mediterranean diet have been 
operationalized as a dietary score using a specific and 
validated score: the Mediterranean diet (MED) score [7].
It is however difficult to disentangle the effects of diet 
from those of the risk factors for CV disease, which are 
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Indeed, most of previous studies evaluated old subjects 
at high CV risk [1–6, 8, 9, 11, 15, 16, 26, 28–30, 33]. Only 
few studies have excluded from the analyses individuals 
with pre-existing CV diseases or diabetes [7, 12, 13, 32] 
or included younger, healthy individuals [10, 14, 16, 19, 
20]. No study has explicitly considered subjects according 
to their CV risk.
The primary objective of this study was to assess 
whether the MED score was associated with all-cause 
mortality in individuals at low CV risk from a popula-
tion-based cohort, after a 12-year mean follow-up. The 
secondary aim was to determine whether this score was 
associated with the incidence of CV events and CV mor-
tality in the same individuals.
Patients and methods
Patients
All the 45–64 years old Caucasian patients (n = 1877) of 
six general practitioners were invited to participate in a 
metabolic screening in 2001–2003. These subjects were 
representative of the Local Health Units of the prov-
ince of Asti (northwestern Italy) [37, 38]. Of these, 1658 
(88.3 %) subjects gave their written informed consent to 
participate while 219 patients declined. Both the partici-
pants and non-participants were similar to the resident 
population of the corresponding age range in terms of 
male prevalence, education level, prevalence of known 
diabetes, and residence in a rural area [37]. The study was 
approved by the local ethics committee. All procedures 
conformed to the principles of the Helsinki Declaration.
Methods
In the morning, after fasting, weight, height, waist cir-
cumference, and blood pressure were measured. Glucose, 
insulin, total cholesterol, HDL-cholesterol, triglyceride 
and high-sensitivity C-reactive protein (CRP) levels were 
determined. If the serum glucose value was ≥110 mg/dl, 
a second fasting glucose determination was performed. 
Two blood pressure measurements were made with 
mercury sphygmomanometers and the appropriate cuff 
sizes after a 10-min rest in the sitting position, and the 
values reported are the means of the two measurements. 
The waist circumference was measured by a plastic tape 
meter at the level of the umbilicus by trained physicians.
All participants completed the semi-quantitative food-
frequency questionnaire used in the European Prospec-
tive Investigation into Cancer and Nutrition (EPIC) 
studies [39] and the Minnesota Leisure Time Physical 
Activity questionnaire [40].
From January to November 2014, patients underwent 
a blood sample analysis and a follow-up medical exami-
nation by their general practitioners. Information on 
the vital status of each patient and the causes of death of 
those who died was collected from the demographic files 
of the town of residence or death.
The laboratory methods have been described previ-
ously [37, 38]. All samples were run blindly.
Mediterranean diet (MED) score
The validated EPIC food questionnaire assessed the aver-
age frequency and portion intake of 148 foods consumed 
during the 12 months prior to enrolment [39]. For each 
food item, the participants had to mark if the food or 
dish was consumed or not during the previous year. For 
all food items consumed, the subjects had to select their 
typical portion size with the help of photographs, the 
consumption frequency and the time period (day, week, 
month or year), which suited them best. Questions about 
the type of fat for cooking were also included. A dietician, 
blinded to the study details, checked all questionnaires 
for completeness, internal coherence, and plausibility. In 
case of uncertain answers, patients were interviewed by 
the dietician.
The reliability of the reported energy intake was 
assessed by calculating the ratio of estimated energy 
intake to predicted basal metabolic rate, using age- and 
sex-specific formulas derived by Schofiled [41]. Subjects 
with a ratio <0.88 were classified as under-reporters [42].
The MED score, assessed in accordance to Tricho-
poulou et  al. [1, 7], included 9 components and ranged 
from 0 (minimum conformity) to 9 (maximum conform-
ity). Energy-adjusted intakes at or above the sex-specific 
median intake for healthy foods or nutrients were given 
1 point [fruits and nuts, legumes, vegetables (exclud-
ing potatoes), grains, fish, and monounsaturated fat—
saturated fat ratio]; intakes lower than the sex-specific 
median intake for unhealthy food were given 1 point 
[dairy and meat] and alcohol consumption within sex-
specific ranges was given 1 point (10–30 and 5–25 g/day 
for men and women, respectively). The original alcohol 
consumption proposed for men was 10–50 g/day [1, 7]; it 
was reduced to 10–30 g/day, in line with Italian guideline 
[43].
The intakes were adjusted for total energy by using the 
residual method [44].
The MED score was analyzed both as continuous vari-
able (per 1-unit increase) and categorical variable: low- 
(0–3 units), medium- (4–5 units), and high-adherence 
(6–9 units).
Definitions
The baseline CV risk score was estimated with the 
Framingham risk score [45]. A score <10 defined low-risk 
individuals.
The physical activity level was calculated as the product 
of the duration and frequency of each activity (in hours/
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week), weighted by an estimate of the metabolic equiva-
lent of the activity and summed for the activities per-
formed [40].
The diagnosis of CV disease was based on documented 
events that were recorded by the general practitioners 
(i.e. angina, previous myocardial infarction, coronary 
artery by-pass graft or another invasive procedure to 
treat coronary artery disease, transient ischemic attack, 
stroke, gangrene, amputation, vascular surgery, intermit-
tent claudication, absent foot pulses and abnormal bra-
chial and posterior tibial blood pressure using Doppler 
techniques).
The underlying cause of death was available for all the 
deceased patients and was obtained from the death cer-
tificate and coded according to the ICD-9 (International 
Classification of Diseases, Ninth Revision). Deaths due to 
CV diseases corresponded to ICD codes 410–414 (coro-
nary artery diseases), 430–438 (strokes), 440 (peripheral 
artery diseases) and other ICD codes between 390–459 
and 798.1 (other CV diseases).
Statistical analyses
The distributions of alcohol intake, fasting insulin, tri-
glycerides and CRP values were skewed. The character-
istics of the cohort according to the MED score were 
analyzed by ANOVA, Kruskal–Wallis tests (for not-nor-
mally distributed variables) or the χ2-test, as appropriate.
To test for a linear dose–response relation, the MED 
score was considered as continuous variables per 1-point 
increment. In addition, the HR were calculated by com-
paring categorical variable: low, medium, and high adher-
ence to the Mediterranean diet.
Survival data were modeled through Cox-proportional-
hazards regression, by estimating the hazard ratio (HR) 
and its 95  % confidence intervals (CI), with successive 
degrees of adjustments. The model 1 was adjusted for 
age, sex, BMI as continuous variables; the model 2 was 
additionally adjusted for actual smoking (1 = yes; 0 = no) 
and values of systolic and diastolic blood pressure, fast-
ing glucose, total and HDL-cholesterol (continuous); the 
model 3 was additionally adjusted for education (3 cat-
egories: primary schools, secondary schools, university), 
living in a rural area (1 = yes; 0 = no), METs (h/week), 
and baseline CV score (continuous variable).
Separate analyses were performed for total mortal-
ity, CV mortality and incidence of CV events. In all 
these analyses, individuals in the first category of MED 
score (low adherence) were considered as the reference 
group, and the other groups were introduced as dummy 
variables.
Sensitivity analyses in order to minimize the possibil-
ity that diet was changed in response to morbidity were 
also ran after excluding individuals with CV disease or 
diabetes at baseline. Finally, analyses were repeated after 
the exclusion of under-reporters.
Results
The characteristics of individuals with CV risk <10 and 
≥10 were quite different (Table 1).
During a mean follow-up of 12-year, 220 individuals 
died, 84 of deaths were due to CV causes, and 125 new 
CV events were recorded by the general practitioners. 
Overall, individuals who died during follow-up, showed 
a worse metabolic pattern at baseline: they were more 
frequently male and showed a significantly higher age, 
BMI, waist circumference, fasting glucose, total choles-
terol and triglycerides and lower HDL cholesterol (data 
not shown).
Mean and median MED score values were 3.7 and 4, 
respectively. Out of all participants, 768 (46.3 %) showed 
a low adherence, 685 (41.3 %) a medium adherence, and 
205 (12.4  %) a high adherence to the Mediterranean 
diet (Table  2). The number of under-reporters was 138 
(8.3  %). Among the three groups of adherence to the 
Mediterranean diet, the percentage of under-reporters 
did not differ (8.1, 8.7 and 8.4  % in the low-, medium-, 
and high-adherent groups, respectively).
In both groups (CV risk <10 and ≥10), the dietary pat-
tern improved with increased adherence to the Mediter-
ranean diet, as expected (Table 2). Values of BMI, waist 
circumference, fasting glucose and insulin significantly 
decreased from low to high diet adherence only in par-
ticipants with CV risk ≥10 (Table 2).
Modeled as a continuous variable, the MED score pre-
dicted incident CV events in individuals with CV risk <10 
and ≥10, while it was inversely associated with all-cause 
and CV mortality in the low-risk group only (Table  3). 
When the MED score was categorically modeled, the 
number of events decreased linearly with increasing 
adherence to the Mediterranean diet (Table  4). Because 
of the presence of few events in the categories 4–5 and 
6–9, the 95 % CI were large. 
Results did not significantly changed after excluding 
either patients with CV disease or diabetes at baseline, 
the under-reporters, or those on aspirin and/or on statin 
treatment.
Discussion
A high adherence to the Mediterranean nutritional pat-
tern favorably affected life expectancy and the risk of CV 
events and death among middle-aged individuals with a 
low CV risk.
The components of the Mediterranean diet are a high 
ratio of monounsaturated (olive oil) to saturated fat; 
moderate ethanol consumption (primarily wine); high 
consumption of legumes, cereals, vegetables, fruits and 
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nuts; moderate/high consumption of fish; low consump-
tion of milk and dairy products; low consumption of 
meat and meat products. Therefore, it is a nutritional pat-
tern low in saturated fat, high in monounsaturated fat, 
complex carbohydrates and fiber and its beneficial effects 
on CV events and mortality may be mediated by the anti-
oxidant, anti-inflammatory and platelet-reducing effects 
of its components [1–33, 46]. Furthermore, the Mediter-
ranean diet is inversely associated with visceral adipose 
tissue, advanced glycation end-products and modifica-
tion of circulating adipocytokines, with increase in adi-
ponectin concentrations [26, 47–51]. Finally, intervention 
trials with a Mediterranean-style diet reduced values of 
circulating inflammatory parameters, oxidized low-den-
sity lipoproteins, markers of endothelial dysfunction [52, 
53], and the incidence of CV risk factors, type 2 diabetes 
and the metabolic syndrome [54, 55].
However, if diabetes, hypertension, hypercholes-
terolemia, and chronic subclinical inflammation are 
potential intermediates of the association between the 
Mediterranean diet and CV outcomes because of the 
effects of the dietary pattern in modifying these risk fac-
tors, the reason why an increased MED score was more 
favorable in our low-risk individuals with respects to 
individuals with a CV risk ≥10 seems not obvious.
The diagnosis of most of these conditions may affect 
one’s diet with better adherence to dietary recommen-
dations, but this seems not the case in our cohort, since 
mean intakes of food groups were similar among individ-
uals with CV risk <10 and ≥10 (Table  2). Furthermore, 
the lack of a relevant attenuation of associations when 
these risk factors were adjusted for, and the absence of 
significant changes in the results after excluding from the 
analyses patients with CV diseases or diabetes at baseline 
did not support the possibility of mediation.
A possible explanation might be the increased influ-
ence of the higher levels of risk factors in individuals 
at higher risk, which might have obscured the relation-
ships between outcomes and the MED score. Our indi-
viduals with a CV risk ≥10 were above all females and 
5–6 years older than those with a CV risk <10. A more 
complex relationship between diet and survival with age 
has been reported, because of a selective earlier mortality 
of more susceptible individuals and relative immunity of 
survivors. Furthermore, an increased number of deaths 
occurred in our patients with a CV risk ≥10 compared 
to those with a CV risk <10, and an increased influence 
of competing causes of death may have altered the asso-
ciation with mortality in the former individuals. Finally, 
medical treatments during follow-up of the patients at 
higher risk could have modified these associations, thus 
the advancement in medical practice should be consid-
ered as a potential condition modifying survival.
Our results are in agreement with other studies which 
found a lower predicting role of dietary scores in older 
individuals [4], and stronger associations in younger and 
healthier individuals [7, 12–14, 16, 19, 20, 32].
It could be therefore hypothesized that a healthy diet is 
more important for the prevention of CV diseases than 
for its management. This is a highly debated topic and, 
contrarily to our results, other authors have shown that 
the association between the Mediterranean diet and the 
risk of death was three–five-fold higher among patients 
with CV diseases than healthy individuals [11]. Even if 
we cannot exclude the possibility that increased CV risk 
Table 1 Clinical and  laboratory characteristics of  the 
cohort by baseline CV risk score
Mean ± SD
p values obtained by ANOVA or the χ2-test, as appropriate
CV cardiovascular, CRP C-reactive protein
* Metabolic equivalent of activity (h/week)
** p values obtained by the Kruskal–Wallis test
CV risk score <10 CV risk score ≥10 p
Number 897 761
Age (years) 52.0 ± 5.0 57.6 ± 4.8 <0.001
Males (%) 57.6 34.6 <0.001
Living in a rural area 
(%)
42.4 38.0 0.07
University (%) 9.9 4.6
Secondary school (%) 21.3 13.9
Primary school (%) 68.8 81.5 <0.001
Current smokers (%) 14.3 35.1 <0.001
METS (h/week)* 22.2 ± 10.3 20.6 ± 10.4 0.002
BMI (kg/m2) 25.8 ± 4.4 27.5 ± 4.7 <0.001
Waist circumference 
(cm)
89.4 ± 12.5 93.7 ± 13.2 <0.001
Systolic blood pressure 
(mmHg)
127.5 ± 13.0 141.0 ± 15.9 <0.001
Diastolic blood pres-
sure (mmHg)
81.1 ± 8.6 85.9 ± 9.5 <0.001
Fasting glucose (mg/
dl)
99.4 ± 16.7 111.4 ± 40.4 <0.001
Fasting insulin (µU/
ml)**
8.1 ± 4.4 9.3 ± 5.4 <0.001
Total cholesterol (mg/
dl)
203.9 ± 36.0 232.3 ± 40.3 <0.001
HDL cholesterol (mg/
dl)
62.1 ± 14.2 58.4 ± 12.1 <0.001
Triglycerides (mg/dl)** 122.1 ± 69.8 159.4 ± 109.7 <0.001
CRP (mg/l)** 2.2 ± 5.0 3.2 ± 6.4 <0.001
CV risk score 6.3 ± 2.0 17.1 ± 7.3 <0.001
CV diseases at baseline 
(%)
0 12.0 <0.001
Statin use (%) 2.0 6.6 <0.001
Aspirin use (%) 1.0 10.5 <0.001
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factors might have attenuated the relationships between 
outcomes and the MED score, our data clearly suggest 
the importance of healthy dietary pattern in low-risk 
individuals, since a low adherence to the Mediterranean 
diet was significantly associated with unfavorable events 
during follow-up.
The association with the MED score appeared to be 
stronger for mortality from CV diseases than from all-
causes, albeit the CIs were wide due to the reduced num-
ber of events. This was in line with other studies finding a 
stronger protective role of the Mediterranean diet against 
CV death [7, 8, 15, 16, 25]. Indeed, among all-cause mor-
tality, other conditions unlikely to be related to diet, such 
as injuries, infections, suicides, were comprised. Once 
we controlled for confounding, this inverse association 
was robust. A realistically achievable change in diet—e.g. 
a 1 point increment—was associated with a significant 
reduction in both CV mortality and CV events in individ-
uals with a CV risk <10. Accordingly, most observational 
studies specifically focused on nonfatal CV events found 
Table 2 Characteristics of the cohort by CV risk and MED score group
Mean ± SD
p values obtained by ANOVA or the χ2-test, as appropriate
CV cardiovascular, CRP C-reactive protein
* Metabolic equivalent of activity (h/week)
** p values obtained by the Kruskal–Wallis test
0–3 4–5 ≥6 p 0–3 4–5 ≥6 p
Number 406 379 112 362 306 93
Age (years) 51.9 ± 5.4 52.0 ± 4.6 52.1 ± 4.7 0.96 57.7 ± 4.9 57.5 ± 4.8 57.7 ± 4.4 0.81
Males (%) 56.9 58.3 58.0 0.92 36.5 36.9 19.4 0.004
Living in a rural area (%) 44.6 41.4 37.5 0.36 40.3 34.3 40.9 0.23
University (%) 7.6 10.8 15.2 4.4 4.6 5.4
Secondary school (%) 21.9 20.8 20.5 13.3 14.4 15.1
Primary school (%) 70.4 68.3 64.3 0.18 82.3 81.1 79.6 0.98
Current smokers (%) 15.8 11.9 17.0 0.20 30.2 40.9 35.5 0.02
METS (h/week)* 22.7 ± 11.2 21.6 ± 9.7 22.1 ± 10.2 0.34 20.6 ± 10.5 20.7 ± 10.1 20.0 ± 10.1 0.87
BMI (kg/m2) 26.0 ± 4.6 25.7 ± 4.3 25.2 ± 4.2 0.22 27.8 ± 4.7 27.8 ± 4.9 25.6 ± 3.8 <0.001
Waist circumference (cm) 89.7 ± 12.6 89.4 ± 12.6 88.0 ± 11.9 0.46 94.9 ± 12.6 92.2 ± 13.4 87.1 ± 12.7 <0.001
Systolic blood pressure 
(mmHg)
127.6 ± 13.4 127.0 ± 12.5 128.8 ± 13.3 0.45 141.1 ± 16.2 141.2 ± 15.9 139.9 ± 14.6 0.77
Diastolic blood pressure 
(mmHg)
81.8 ± 8.5 80.1 ± 8.4 81.6 ± 9.4 0.01 86.1 ± 9.5 85.8 ± 9.6 85.2 ± 8.8 0.66
Fasting glucose (mg/dl) 99.5 ± 16.1 99.9 ± 18.7 97.3 ± 11.0 0.35 120.0 ± 53.0 105.7 ± 23.0 97.3 ± 11.6 <0.001
Fasting insulin (µU/ml)** 8.3 ± 5.0 7.9 ± 3.8 7.8 ± 3.2 0.43 9.7 ± 6.4 9.2 ± 4.6 7.8 ± 2.6 0.007
Total cholesterol (mg/dl) 203.0 ± 35.5 205.4 ± 36.1 202.3 ± 37.9 0.57 231.1 ± 43.8 231.2 ± 37.4 240.6 ± 34.6 0.10
HDL cholesterol (mg/dl) 62.2 ± 14.5 61.7 ± 14.0 63.1 ± 13.9 0.68 58.0 ± 11.9 58.2 ± 12.1 60.5 ± 12.6 0.18
Triglycerides (mg/dl)** 121.8 ± 71.1 124.0 ± 73.9 117.2 ± 48.2 0.81 165.9 ± 135.4 154.5 ± 82.3 150.7 ± 68.5 0.48
CRP (mg/l)** 2.1 ± 3.3 2.5 ± 6.8 1.7 ± 2.1 0.71 3.6 ± 8.3 2.9 ± 4.1 2.5 ± 2.8 0.13
CV risk score 6.3 ± 2.0 6.3 ± 2.0 6.3 ± 1.9 0.90 17.2 ± 8.1 16.9 ± 6.7 17.3 ± 6.0 0.80
Total caloric intake (kcal/day) 2169.3 ± 671.6 2058.4 ± 668.6 2126.5 ± 597.1 0.06 2022.6 ± 663.0 2025.6 ± 700.4 1964.8 ± 592.6 0.73
Vegetables (g/day)** 170.6 ± 90.6 203.3 ± 95.7 250.0 ± 144.9 <0.001 157.5 ± 90.0 195.9 ± 100.9 241.8 ± 145.9 <0.001
Legumes (g/day)** 10.8 ± 11.3 18.1 ± 14.6 21.2 ± 14.6 <0.001 14.2 ± 16.2 18.2 ± 15.7 20.9 ± 14.2 <0.001
Fruits and nuts (g/day)** 254.3 ± 157.8 412.5 ± 194.8 576.1 ± 286.1 <0.001 273.8 ± 145.9 425.2 ± 218.5 560.2 ± 154.8 <0.001
Dairy products (g/day)** 213.8 ± 185.4 169.4 ± 235.1 96.1 ± 84.0 <0.001 255.8 ± 222.4 154.2 ± 135.4 97.6 ± 78.5 <0.001
Cereals (g/day)** 209.4 ± 134.4 233.2 ± 118.0 265.5 ± 104.6 <0.001 183.5 ± 123.8 212.6 ± 94.7 257.9 ± 90.7 <0.001
Meats and meat products (g/
day)
170.1 ± 116.7 138.3 ± 64.1 118.1 ± 49.1 <0.001 143.8 ± 72.1 139.1 ± 76.6 112.6 ± 46.8 <0.001
Fish (g/day)** 24.5 ± 21.3 38.1 ± 21.9 55.3 ± 35.1 <0.001 24.8 ± 20.1 38.4 ± 25.8 52.3 ± 34.9 <0.001
Monounsaturated: saturated 
fat ratio
1.4 ± 0.3 1.6 ± 0.3 1.9 ± 0.3 <0.001 1.4 ± 0.3 1.6 ± 0.3 2.0 ± 0.3 <0.001
Alcohol (g/day)** 21.1 ± 25.0 17.5 ± 20.6 17.4 ± 18.5 0.31 16.4 ± 24.8 16.5 ± 22.6 12.3 ± 11.8 0.32
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a significantly reduced incidence of CV morbidity in indi-
viduals with a high adherence to the Mediterranean diet 
[6, 13, 17, 19, 22, 23, 27, 29–31]. Furthermore, our results 
were consistent with the protective effect found in rand-
omized trials both in primary prevention [26] and against 
re-infarction in survivors of myocardial infarction [2, 56].
Several dietary factors, not included in the MED score, 
have been demonstrated to be important for CV risk, 
such as trans fatty acids and n-3 fatty acids. However, the 
omitted dietary components are likely to be associated 
with foods that are included in the MED score. Further-
more, the overall dietary pattern was found to be more 
important for health than individual nutritional compo-
nents [1, 7, 9, 10] since there may be biologic interactions 
and complex and co-linear associations between different 
components of the diet and, above all, people do not con-
sume isolated components but a complex of nutrients.
This study was performed in Northern Italy, in Pied-
mont, a region not facing the sea and bordering with 
France. This is the reason why the proportion of indi-
viduals with a high adherence to the Med score was low, 
differently from other areas of Italy, such as Southern 
Italy, where the consumptions of olive oil, fish, vegeta-
bles and legumes were higher [29, 33, 46, 57]. Neverthe-
less, a modest adherence to the Mediterranean diet was 
found to be useful in the prevention of CV events [17]. 
Furthermore, a higher MED score did not reflect per se 
a true Mediterranean diet; indeed, adherence to alterna-
tive variants of the Mediterranean diet showed beneficial 
effects on many outcomes [12, 13, 15, 27, 28, 30, 31], thus 
suggesting the possibility of adapting this dietary pattern 
to the geographical particularities and cultural habits of 
different populations.
Limitations and strengths
Some study limitations deserve discussion. Subjects with 
early symptoms of CV diseases may have altered their 
diet and lifestyle. However, excluding cases with CV dis-
eases at baseline and adjusting for CV risk factors did 
not notably alter the associations. Dietary measurement 
errors are almost unavoidable; however, the exclusion of 
under-reporting did not change the relationship between 
the scores and the outcomes. We only evaluated dietary 
pattern at baseline, and participants could have changed 
Table 3 Association of MED score as continuous variable with outcomes by Cox-regression models
Model 1: adjusted for age, sex, BMI
Model 2: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterol
Model 3: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterol, rural area, exercise level, baseline 
CV risk score and education
MED score All CV risk score <10 CV risk score ≥10
Incident CV events
 Number 125 47 78
HR 95 % CI p HR 95 % CI p HR 95 % CI p
Crude 0.83 0.73–0.93 0.002 0.80 0.66–0.98 0.03 0.85 0.73–0.99 0.04
Model 1 0.84 0.74–0.94 0.005 0.80 0.66–0.98 0.03 0.86 0.74–1.01 0.06
Model 2 0.83 0.74–0.94 0.004 0.80 0.65–0.99 0.04 0.85 0.72–0.99 0.04
Model 3 0.84 0.74–0.95 0.005 0.79 0.65–0.97 0.03 0.85 0.72–0.99 0.04
CV mortality
 Number 84 34 50
HR 95 % CI p HR 95 % CI p HR 95 % CI p
Crude 0.83 0.71–0.96 0.01 0.75 0.59–0.95 0.02 0.89 0.73–1.08 0.24
Model 1 0.86 0.73–0.99 0.04 0.76 0.59–0.96 0.02 0.95 0.78–1.16 0.61
Model 2 0.87 0.75–1.02 0.09 0.74 0.58–0.95 0.02 0.96 0.78–1.18 0.70
Model 3 0.88 0.75–1.02 0.09 0.75 0.58–0.96 0.02 0.94 0.76–1.15 0.53
All-cause mortality
 Number 220 90 130
HR 95 % CI p HR 95 % CI p HR 95 % CI p
Crude 0.91 0.83–0.99 0.03 0.83 0.72–0.96 0.01 0.97 0.86–1.09 0.56
Model 1 0.93 0.85–1.02 0.12 0.84 0.72–0.97 0.01 1.02 0.91–1.16 0.71
Model 2 0.94 0.85–1.10 0.17 0.84 0.72–0.97 0.02 1.02 0.90–1.15 0.75
Model 3 0.94 0.85–1.03 0.20 0.83 0.72–0.96 0.01 1.02 0.90–1.15 0.81
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Table 4 Association of MED score as categorized variable with outcomes by Cox-regression models
Mediterranean diet score
All Score 0–3 Score 4–5 Score 6–9
Number 768 685 205
Incident CV events 72 42 11
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.65; 0.44–0.95; 0.03 0.57; 0.30–1.07; 0.08
Model 1 1 0.68; 0.46–0.99; 0.05 0.60; 0.32–1.14; 0.12
Model 2 1 0.67; 0.45–0.98; 0.04 0.58; 0.31–1.11; 0.10
Model 3 1 0.68; 0.46–1.00; 0.05 0.59; 0.31–1.12; 0.11
CV mortality 49 28 7
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.63; 0.40–1.00; 0.05 0.52; 0.24–1.16; 0.11
Model 1 1 0.65; 0.41–1.03; 0.07 0.65; 0.30–1.45; 0.30
Model 2 1 0.68; 0.42–1.09; 0.11 0.69; 0.31–1.54; 0.37
Model 3 1 0.68; 0.42–1.09; 0.11 0.69; 0.31–1.54; 0.37
All-cause mortality 116 82 22
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.78; 0.59–1.03; 0.08 0.70; 0.44–1.10; 0.12
Model 1 1 0.79; 0.59–1.05; 0.10 0.83; 0.52–1.31; 0.42
Model 2 1 0.79; 0.59–1.05; 0.11 0.84; 0.53–1.34; 0.47
Model 3 1 0.80; 0.60–1.06; 0.12 0.85; 0.54–1.35; 0.50
CV risk score <10
Number 406 379 112
Incident CV events 28 16 3
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.61; 0.33–1.12; 0.11 0.38; 0.12–1.26; 0.11
Model 1 1 0.62; 0.34–1.15; 0.13 0.40; 0.12–1.31; 0.13
Model 2 1 0.62; 0.33–1.16; 0.14 0.41; 0.12–1.35; 0.14
Model 3 1 0.61; 0.33–1.14; 0.12 0.38; 0.11–1.27; 0.12
CV mortality 21 10 3
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.50; 0.24–1.07; 0.07 0.51; 0.15–1.71; 0.28
Model 1 1 0.52; 0.24–1.11; 0.09 0.55; 0.16–1.86; 0.34
Model 2 1 0.45; 0.21–0.97; 0.04 0.60; 0.18–2.02; 0.41
Model 3 1 0.46; 0.21–1.01; 0.05 0.59; 0.17–2.01; 0.40
All-cause mortality 50 31 9
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.65; 0.42–1.02; 0.06 0.64; 0.31–1.30; 0.22
Model 1 1 0.66; 0.42–1.04; 0.07 0.67; 0.33–1.37; 0.27
Model 2 1 0.65; 0.41–1.02; 0.06 0.68; 0.33–1.38; 0.28
Model 3 1 0.65; 0.41–1.03; 0.06 0.66; 0.32–1.35; 0.26
CV risk score ≥10
Number 362 306 93
Incident CV events 44 26 8
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their diets before outcomes occurred. However, such 
changes would be more likely to lead to underestimation 
of the identified associations, as recently shown [58], and 
dietary patterns appear to be stable, in particular adher-
ence to the Mediterranean diet [28]. Furthermore, the 
protective effects of the Mediterranean diet were main-
tained up to several years [2]. Residual confounding due 
to the healthier lifestyle of individuals more adherent 
to healthy diet cannot be excluded, even if we took into 
account most confounders in the analyses. We cannot 
exclude the possibility of a survival bias, which however 
would have rather weakened the association between 
lifestyle factors and survival.
The MED score is based on cohort- and sex-specific 
median values across respectively 9 food categories 
and allocates equal weights to each component of the 
score, thus arbitrarily assuming the same importance for 
every component; indeed, it was extensively used and 
validated in literature [1–33]. Finally, owing to the small 
number of observed events, our CIs of the hazard ratios 
were wide.
The strengths of the present cohort study were the 
longitudinal design with a long follow-up; the complete-
ness of data at follow-up, which limited the possibility of 
selection bias; the population-based nature; the availabil-
ity of information on several variables, which were intro-
duced as possible confounders in the analyses.
Conclusions
Efforts to promote adherence to a healthy dietary pattern 
as close as possible to the Mediterranean diet appear to 
be worthwhile in individuals at low CV risk.
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Table 4 continued
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.70; 0.43–1.14; 0.14 0.71; 0.33–1.50; 0.37
Model 1 1 0.71; 0.44–1.16; 0.17 0.76; 0.35–1.63; 0.48
Model 2 1 0.69; 0.42–1.13; 0.14 0.72; 0.33–1.55; 0.40
Model 3 1 0.71; 0.43–1.16; 0.18 0.68; 0.31–1.45; 0.32
CV mortality 28 18 4
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.74; 0.41–1.35; 0.33 0.54; 0.19–1.54; 0.25
Model 1 1 0.73; 0.40–1.33; 0.30 0.81; 0.28–2.34; 0.70
Model 2 1 0.79; 0.43–1.44; 0.44 0.81; 0.28–2.37; 0.70
Model 3 1 0.70; 0.37–1.29; 0.26 0.76; 0.26–2.20; 0.61
All-cause mortality 66 51 13
HR HR; 95 % CI; p HR; 95 % CI; p
Crude 1 0.90; 0.62–1.29; 0.56 0.74; 0.41–1.35; 0.33
Model 1 1 0.89; 0.62–1.28; 0.54 1.06; 0.58–1.94; 0.84
Model 2 1 0.90; 0.62–1.31; 0.60 1.02; 0.55–1.88; 0.95
Model 3 1 0.88; 0.61–1.29; 0.52 1.00; 0.54–1.83; 0.99
Model 1: adjusted for age, sex, BMI
Model 2: adjusted for age, sex, BMI, smoking habits, systolic and diastolic blood pressure, fasting glucose, total and HDL-cholesterol
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